MilliporeSigma Accelerates Scale Up of Lipids to Meet Covid-19 Demand
– Introduces new synthetic cholesterol product nine months ahead of schedule – Offers high purity, scalability, and consistent quality – One of a few companies that produces lipids in quantities needed to meet demand for mRNA therapeutics, including Pfizer-BioNTech Covid-19 Vaccine…
Comments Off on MilliporeSigma Accelerates Scale Up of Lipids to Meet Covid-19 Demand